Wellington Management Group’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-231,847
| Closed | -$3.51M | – | 2184 |
|
|
2022
Q3 | $3.51M | Sell |
231,847
-35,718
| -13% | -$415K | ﹤0.01% | 1376 |
|
|
2022
Q2 | $2.01M | Hold |
267,565
| – | – | ﹤0.01% | 1538 |
|
|
2022
Q1 | $2.44M | Buy |
267,565
+60,296
| +29% | +$465K | ﹤0.01% | 1559 |
|
|
2021
Q4 | $1.46M | Buy |
+207,269
| New | +$2.17M | ﹤0.01% | 1735 |
|
|
2021
Q1 | – | Sell |
-31,025
| Closed | -$418K | – | 2219 |
|
|
2020
Q4 | $418K | Sell |
31,025
-814,934
| -96% | -$9.85M | ﹤0.01% | 1750 |
|
|
2020
Q3 | $9.96M | Sell |
845,959
-263,799
| -24% | -$3.21M | ﹤0.01% | 1101 |
|
|
2020
Q2 | $16.4M | Sell |
1,109,758
-5,626,464
| -84% | -$83.2M | ﹤0.01% | 964 |
|
|
2020
Q1 | $90.9M | Buy |
6,736,222
+495,181
| +8% | +$9.4M | 0.02% | 485 |
|
|
2019
Q4 | $151M | Sell |
6,241,041
-131,244
| -2% | -$2.72M | 0.03% | 469 |
|
|
2019
Q3 | $122M | Buy |
6,372,285
+12,359
| +0.2% | +$283K | 0.03% | 495 |
|
|
2019
Q2 | $188M | Buy |
6,359,926
+41,366
| +0.7% | +$1.59M | 0.04% | 382 |
|
|
2019
Q1 | $300M | Buy |
6,318,560
+65,861
| +1% | +$2.9M | 0.07% | 282 |
|
|
2018
Q4 | $226M | Buy |
6,252,699
+448,952
| +8% | +$21.1M | 0.06% | 309 |
|
|
2018
Q3 | $357M | Buy |
5,803,747
+478,458
| +9% | +$30.8M | 0.08% | 262 |
|
|
2018
Q2 | $360M | Sell |
5,325,289
-44,062
| -0.8% | -$2.47M | 0.08% | 257 |
|
|
2018
Q1 | $291M | Buy |
5,369,351
+307,888
| +6% | +$17.2M | 0.07% | 294 |
|
|
2017
Q4 | $302M | Buy |
5,061,463
+191,247
| +4% | +$11.6M | 0.07% | 277 |
|
|
2017
Q3 | $237M | Buy |
4,870,216
+1,552,110
| +47% | +$84.7M | 0.05% | 307 |
|
|
2017
Q2 | $174M | Buy |
3,318,106
+422,180
| +15% | +$19.7M | 0.04% | 361 |
|
|
2017
Q1 | $131M | Sell |
2,895,926
-1,009
| -0% | -$45K | 0.03% | 413 |
|
|
2016
Q4 | $110M | Sell |
2,896,935
-362,943
| -11% | -$13.7M | 0.03% | 470 |
|
|
2016
Q3 | $123M | Buy |
3,259,878
+50,482
| +2% | +$1.11M | 0.03% | 427 |
|
|
2016
Q2 | $56.5M | Buy |
3,209,396
+171,413
| +6% | +$2.77M | 0.01% | 642 |
|
|
2016
Q1 | $36.9M | Sell |
3,037,983
-468,663
| -13% | -$7.42M | 0.01% | 755 |
|
|
2015
Q4 | $85.4M | Buy |
3,506,646
+86,406
| +3% | +$2.02M | 0.02% | 513 |
|
|
2015
Q3 | $60.7M | Buy |
3,420,240
+55,408
| +2% | +$1M | 0.02% | 612 |
|
|
2015
Q2 | $59.4M | Sell |
3,364,832
-1,274
| -0% | -$23.4K | 0.02% | 663 |
|
|
2015
Q1 | $105M | Buy |
3,366,106
+41,936
| +1% | +$1.22M | 0.03% | 489 |
|
|
2014
Q4 | $97M | Buy |
3,324,170
+19,790
| +0.6% | +$502K | 0.03% | 521 |
|
|
2014
Q3 | $68.4M | Buy |
3,304,380
+845,181
| +34% | +$16.7M | 0.02% | 614 |
|
|
2014
Q2 | $60.9M | Buy |
2,459,199
+542,451
| +28% | +$9.4M | 0.02% | 672 |
|
|
2014
Q1 | $40.6M | Buy |
1,916,748
+261,945
| +16% | +$5.29M | 0.01% | 810 |
|
|
2013
Q4 | $29.7M | Buy |
+1,654,803
| New | +$21.6M | 0.01% | 890 |
|
Wellington Management Group's AERI Position: Q4 2022 in Review
Wellington Management Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 231,847 shares — an estimated $3.51M sold.
Wellington Management Group first reported a position in AERI in Q4 2013 and held it in 33 quarters. The position peaked at $360M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Wellington Management Group reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Wellington Management Group sold 231,847 Aerie Pharmaceuticals shares in Q4 2022, an estimated $3.51M.
- Wellington Management Group first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 33 quarters.
- Wellington Management Group's Aerie Pharmaceuticals position peaked at $360M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.